系统性红斑狼疮患者的疫苗接种更新和特殊考虑。

IF 5.2 2区医学 Q1 RHEUMATOLOGY Current opinion in rheumatology Pub Date : 2024-03-01 Epub Date: 2023-11-16 DOI:10.1097/BOR.0000000000000992

Jammie Law, Cristina Sorrento, Amit Saxena

{"title":"系统性红斑狼疮患者的疫苗接种更新和特殊考虑。","authors":"Jammie Law, Cristina Sorrento, Amit Saxena","doi":"10.1097/BOR.0000000000000992","DOIUrl":null,"url":null,"abstract":"Purpose of review: We review the latest guidelines and note special considerations for systemic lupus erythematosus (SLE) patients when approaching vaccination against SARS-CoV-2, influenza, pneumococcus, herpes zoster, and potentially respiratory syncytial virus (RSV) vaccine in the future.Recent findings: SLE patients have unique infectious risks due to newer treatments and the nature of the disease itself. It is important to balance the benefit of additional protective immunity from updated vaccines against the possible risk of disease activity exacerbations.Summary: It is important to continuously evaluate the safety and immunogenicity of updated vaccines specifically for SLE patients. Additionally, the newly approved RSV vaccine should be considered for this population to reduce severe respiratory illness.","PeriodicalId":11145,"journal":{"name":"Current opinion in rheumatology","volume":" ","pages":"148-153"},"PeriodicalIF":5.2000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vaccination updates and special considerations for systemic lupus erythematosus patients.\",\"authors\":\"Jammie Law, Cristina Sorrento, Amit Saxena\",\"doi\":\"10.1097/BOR.0000000000000992\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose of review: We review the latest guidelines and note special considerations for systemic lupus erythematosus (SLE) patients when approaching vaccination against SARS-CoV-2, influenza, pneumococcus, herpes zoster, and potentially respiratory syncytial virus (RSV) vaccine in the future.Recent findings: SLE patients have unique infectious risks due to newer treatments and the nature of the disease itself. It is important to balance the benefit of additional protective immunity from updated vaccines against the possible risk of disease activity exacerbations.Summary: It is important to continuously evaluate the safety and immunogenicity of updated vaccines specifically for SLE patients. Additionally, the newly approved RSV vaccine should be considered for this population to reduce severe respiratory illness.\",\"PeriodicalId\":11145,\"journal\":{\"name\":\"Current opinion in rheumatology\",\"volume\":\" \",\"pages\":\"148-153\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current opinion in rheumatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/BOR.0000000000000992\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/11/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current opinion in rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/BOR.0000000000000992","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

回顾的目的:我们回顾了最新的指南，并注意到系统性红斑狼疮(SLE)患者在将来接种SARS-CoV-2、流感、肺炎球菌、带状疱疹和潜在的呼吸道合胞病毒(RSV)疫苗时的特殊注意事项。最新发现:由于较新的治疗方法和疾病本身的性质，SLE患者具有独特的感染风险。重要的是要平衡更新疫苗带来的额外保护性免疫的益处与疾病活动加剧的可能风险。总结:持续评估针对SLE患者的新疫苗的安全性和免疫原性是非常重要的。此外，新批准的RSV疫苗应考虑用于这一人群，以减少严重的呼吸道疾病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Vaccination updates and special considerations for systemic lupus erythematosus patients.

Purpose of review: We review the latest guidelines and note special considerations for systemic lupus erythematosus (SLE) patients when approaching vaccination against SARS-CoV-2, influenza, pneumococcus, herpes zoster, and potentially respiratory syncytial virus (RSV) vaccine in the future.

Recent findings: SLE patients have unique infectious risks due to newer treatments and the nature of the disease itself. It is important to balance the benefit of additional protective immunity from updated vaccines against the possible risk of disease activity exacerbations.

Summary: It is important to continuously evaluate the safety and immunogenicity of updated vaccines specifically for SLE patients. Additionally, the newly approved RSV vaccine should be considered for this population to reduce severe respiratory illness.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current opinion in rheumatology 医学-风湿病学

CiteScore

9.70

自引率

2.00%

发文量

审稿时长

6-12 weeks

期刊介绍： A high impact review journal which boasts an international readership, Current Opinion in Rheumatology offers a broad-based perspective on the most recent and exciting developments within the field of rheumatology. Published bimonthly, each issue features insightful editorials and high quality invited reviews covering two or three key disciplines which include vasculitis syndromes, medical physiology and rheumatic diseases, crystal deposition diseases and rheumatoid arthritis. Each discipline introduces world renowned guest editors to ensure the journal is at the forefront of knowledge development and delivers balanced, expert assessments of advances from the previous year.

期刊最新文献

Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis. Imaging in vasculitis. Polymyalgia rheumatica and giant cell arteritis: diagnosis and management. Inclusion body myositis: an update. VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation.